Global Artificial Insemination Market 2022-2028

August 2022 | 66 pages | ID: G43566691268EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the global artificial insemination market was USD 1,847 million in 2021 and is expected to reach USD 3,104 million in 2028 and register a CAGR of 7.7% during the forecast period, 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global artificial insemination market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the artificial insemination industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, source, end user, and region. The global market for artificial insemination can be segmented by type: intracervical, intratubal, intrauterine. Artificial insemination market is further segmented by source: AID, AIH. Based on end user, the artificial insemination market is segmented into: fertility centers, home, hospitals & clinics. On the basis of region, the artificial insemination market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

• intracervical
• intratubal
• intrauterine

By source:

• AID
• AIH

By end user:

• fertility centers
• home
• hospitals & clinics

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The global artificial insemination market report offers detailed information on several market vendors, including FUJIFILM Irvine Scientific, Inc., Genea Limited, Pride Angel Ltd., Rinovum Women's Health, LLC, Vitrolife AB, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global artificial insemination market.
• To classify and forecast the global artificial insemination market based on type, source, end user, region.
• To identify drivers and challenges for the global artificial insemination market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global artificial insemination market.
• To identify and analyze the profile of leading players operating in the global artificial insemination market.

Why Choose This Report

• Gain a reliable outlook of the global artificial insemination market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Intracervical
Intratubal
Intrauterine

PART 6. MARKET BREAKDOWN BY SOURCE

AID
AIH

PART 7. MARKET BREAKDOWN BY END USER

Fertility centers
Home
Hospitals & clinics

PART 8. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 9. KEY COMPANIES

FUJIFILM Irvine Scientific, Inc.
Genea Limited
Pride Angel Ltd.
Rinovum Women's Health, LLC
Vitrolife AB
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER